ArticleProceedings of the National Academy of Sciences of the United States of America2017

Reply to Padmanabhan and Dixit: Hepatitis C virus entry inhibitors for optimally boosting direct-acting antiviral-based treatments.

Hirofumi Ohashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.